Return to search

Association of Single Nucleotide Polymorphisms in Apolipoprotein H (APOH) with Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a major public health problem in the United States. It is estimated that at least 500,000 Americans suffer from (SLE), which is a complex autoimmune disease of primarily unknown etiology. SLE is about three times more common in African Americans (about 1:250 incidence) than in Caucasian Americans (about 1:1000 incidence), and predominantly affects women of child-bearing age (female to male ratio of 9:1). SLE causes a variable amount of morbidity, shortened life expectancy, and substantial total health expenditures, largely due to complications such as thrombosis, atherosclerosis, renal disease, and antiphospholipid syndrome (APS). Genetics plays a significant role in the etiology of SLE; therefore, understanding the underlying genetic influence of this disease is of significant public health importance. This study dealt with the analysis of one of the genes that has been proposed to play a role in the pathogenesis of SLE: apolipoprotein H (APOH gene, apoH protein), also referred to as B2-glycoprotein I (B2-GPI). ApoH is thought to have anti-atherogenic properties and has been shown to be a major target antigen for antiphospholipid antibodies (APA) present in patients with APS. Twelve APOH SNPs (9 TagSNPs and 3 additional functional coding SNPs) were genotyped in 398 women with a clinical diagnosis of SLE and 496 healthy women as controls. The associations of allele and genotype distributions of these 12 SNPs with SLE, race, renal disease in white patients, and APA in black and white patients and controls were analyzed. Significant allelic distribution differences were observed between whites and blacks for 9 of the 12 SNPs, indicating a race-dependent variation. No associations were found between genotype distributions in any of the 12 SNPs and SLE, renal disease, or APA status. However, haplotype analysis revealed six haplotypes that significantly differed in frequency between cases and controls. Of particular interest was one haplotype that was present in 16.2% of cases and 0.6% of controls, suggesting a potential risk factor for SLE. In conclusion, our study suggests that combined effects of APOH SNPs (haplotype) may be implicated in modifying the risk of SLE.

Identiferoai:union.ndltd.org:PITT/oai:PITTETD:etd-04132007-093207
Date26 June 2007
CreatorsCorthell, Leia S
ContributorsM. Ilyas Kamboh, Ph.D., David N. Finegold, M.D., F. Yesim Demirci, M.D.
PublisherUniversity of Pittsburgh
Source SetsUniversity of Pittsburgh
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.library.pitt.edu/ETD/available/etd-04132007-093207/
Rightsunrestricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to University of Pittsburgh or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Page generated in 0.0113 seconds